RU92016471A - Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате - Google Patents
Твердая непористая микросфера, способ ее получения и применение в фармакологическом препаратеInfo
- Publication number
- RU92016471A RU92016471A RU92016471/14A RU92016471A RU92016471A RU 92016471 A RU92016471 A RU 92016471A RU 92016471/14 A RU92016471/14 A RU 92016471/14A RU 92016471 A RU92016471 A RU 92016471A RU 92016471 A RU92016471 A RU 92016471A
- Authority
- RU
- Russia
- Prior art keywords
- preparation
- solid non
- porous microsphere
- pharmaceutical preparation
- pharmaceutical
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title claims 3
- 239000007787 solid Substances 0.000 title claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (1)
- Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате относятся к микросферам на основе активного вещества, способу их получения и применению в фармацевтических композициях, предназначенных для инъекций.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9007416 | 1990-06-14 | ||
FR9007416A FR2663223B1 (fr) | 1990-06-14 | 1990-06-14 | Forme galenique parenterale. |
PCT/EP1991/001096 WO1991019484A1 (fr) | 1990-06-14 | 1991-06-12 | Composition pharmaceutique injectable |
Publications (2)
Publication Number | Publication Date |
---|---|
RU92016471A true RU92016471A (ru) | 1995-03-10 |
RU2104692C1 RU2104692C1 (ru) | 1998-02-20 |
Family
ID=9397598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU92016471A RU2104692C1 (ru) | 1990-06-14 | 1991-06-12 | Твердая непористая микросфера, способ ее получения и суспензия для парентеральной инъекции на основе данных микросфер |
Country Status (30)
Country | Link |
---|---|
US (3) | US5360616A (ru) |
EP (1) | EP0533739B1 (ru) |
JP (1) | JP2675675B2 (ru) |
KR (1) | KR0157439B1 (ru) |
CN (1) | CN1057442C (ru) |
AT (1) | ATE109658T1 (ru) |
AU (1) | AU661275B2 (ru) |
BG (1) | BG61179B1 (ru) |
BR (1) | BR9106545A (ru) |
CA (1) | CA2085344C (ru) |
CZ (1) | CZ286793B6 (ru) |
DE (1) | DE69103419T2 (ru) |
DK (1) | DK0533739T3 (ru) |
ES (1) | ES2059142T3 (ru) |
FI (1) | FI107698B (ru) |
FR (1) | FR2663223B1 (ru) |
HU (1) | HUT68709A (ru) |
IE (1) | IE62679B1 (ru) |
IL (1) | IL98459A (ru) |
NO (1) | NO302998B1 (ru) |
NZ (1) | NZ238542A (ru) |
PL (1) | PL167234B1 (ru) |
PT (1) | PT97975B (ru) |
RU (1) | RU2104692C1 (ru) |
SK (1) | SK280564B6 (ru) |
TN (1) | TNSN91048A1 (ru) |
UA (1) | UA27043C2 (ru) |
UY (1) | UY23240A1 (ru) |
WO (1) | WO1991019484A1 (ru) |
ZA (1) | ZA914550B (ru) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2663224B1 (fr) * | 1990-06-14 | 1995-01-20 | Applicationes Farmaceuticas Sa | Forme galenique parenterale. |
GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
FR2732621B1 (fr) * | 1995-04-10 | 1997-06-06 | Rhone Poulenc Chimie | Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention |
US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
US6028057A (en) * | 1998-02-19 | 2000-02-22 | Thorn Bioscience, Llc | Regulation of estrus and ovulation in gilts |
AU753278B2 (en) * | 1998-02-25 | 2002-10-10 | Abbott Laboratories | Butorphanol sustained release formulations |
US6287693B1 (en) * | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
JP2003526629A (ja) * | 1999-08-20 | 2003-09-09 | ノートン ヘルスケアー リミテッド | 経肺または経鼻投与のための粉末の製造法 |
US20070254009A1 (en) * | 2001-07-13 | 2007-11-01 | Flow Focusing, Inc. | Antibiotic/bone morphogenic protein formulation and method of treatment |
US20070254008A1 (en) * | 2001-07-13 | 2007-11-01 | Flow Focusing, Inc. | Antibiotic formulation and method of treatment |
US20030055075A1 (en) * | 2001-07-13 | 2003-03-20 | Rubsamen Reid M. | Programmable controlled release injectable opioid formulation |
GB0117696D0 (en) * | 2001-07-20 | 2001-09-12 | Bradford Particle Design Plc | Particle information |
SI1820494T1 (sl) * | 2003-06-13 | 2010-08-31 | Skendi Finance Ltd | Mikrodelci, ki sestojijo iz estradiola in holesterola |
US20050032811A1 (en) * | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
AU2004267956B2 (en) | 2003-09-03 | 2010-09-16 | Miscon Trading S.A. | Methods for the treatment of endometriosis |
US7205281B2 (en) | 2003-10-03 | 2007-04-17 | Thorn Bioscience, Llc | Process for the synchronization of ovulation for timed breeding without heat detection |
ES2315721T5 (es) * | 2003-10-23 | 2012-08-24 | Otsuka Pharmaceutical Co., Ltd. | Formulación de aripiprazol inyectable estéril de liberación controlada y procedimiento |
US7413690B1 (en) | 2003-10-29 | 2008-08-19 | The University Of Mississippi | Process and apparatus for producing spherical pellets using molten solid matrices |
US7491263B2 (en) * | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
US7392635B2 (en) * | 2005-06-09 | 2008-07-01 | Tipper Tie, Inc. | Breech loader packaging systems and associated breech loading chutes and methods |
US20070197435A1 (en) * | 2006-02-17 | 2007-08-23 | Webel Stephen K | Process for the synchronization of ovulation for timed breeding without heat detection |
EP2236546B1 (en) | 2006-10-31 | 2011-12-28 | Surmodics Pharmaceuticals, Inc. | Speronized polymer particles |
LT2170279T (lt) | 2007-07-31 | 2018-03-12 | Otsuka Pharmaceutical Co., Ltd. | Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai |
CN102056611A (zh) * | 2008-04-14 | 2011-05-11 | Posi维森纳里解决方案有限责任公司 | 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物 |
US8905913B2 (en) | 2009-04-23 | 2014-12-09 | Jbs United Animal Health Ii Llc | Method and composition for synchronizing time of insemination |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
RU2015125549A (ru) | 2012-11-28 | 2017-01-11 | ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК | Способ для синхронизации времени осеменения молодых свиней |
WO2017105512A1 (en) | 2015-12-18 | 2017-06-22 | Proinvet Innovations S.A. | Formulations and methods for controlling the reproductive cycle and ovulation |
JP2019506443A (ja) * | 2016-02-24 | 2019-03-07 | イースタン バージニア メディカル スクール | 改良された持効性注射用デポ型ブタン酸レボノルゲストレル懸濁製剤 |
CN106063783B (zh) * | 2016-06-16 | 2019-03-12 | 浙江爱生药业有限公司 | 一种黄体酮缓释微囊制剂及其制备方法 |
US11376220B2 (en) | 2017-06-30 | 2022-07-05 | Therio, LLC | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals |
CN115212170B (zh) * | 2021-04-19 | 2024-01-26 | 中国人民解放军军事科学院军事医学研究院 | 一种致密圆整的药物球形微晶及其制备方法和其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE670438A (ru) * | 1964-10-06 | 1966-01-31 | ||
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3928566A (en) * | 1970-08-14 | 1975-12-23 | Du Pont | Lyophilized biological products |
JPS5017525A (ru) * | 1973-06-14 | 1975-02-24 | ||
CA1077842A (en) * | 1975-10-09 | 1980-05-20 | Minnesota Mining And Manufacturing Company | Albumin medicament carrier system |
US4244949A (en) * | 1978-04-06 | 1981-01-13 | The Population Council, Inc. | Manufacture of long term contraceptive implant |
US4349580A (en) * | 1978-08-18 | 1982-09-14 | Queen's University At Kingston | Process and solution for preserving green plant tissues |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4349530A (en) * | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
IL79407A (en) * | 1985-08-01 | 1991-03-10 | Theragenics Corp | System and method for delivering insoluble material into a living body |
ATE74009T1 (de) * | 1986-08-11 | 1992-04-15 | American Cyanamid Co | Zusammensetzungen zur parenteralen verabreichung und deren verwendung. |
US4837381A (en) * | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
US4892734A (en) * | 1987-04-06 | 1990-01-09 | Endocon, Inc. | Dispensing paste for forming medicinal pellets |
US4748024A (en) * | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
ATE109941T1 (de) * | 1987-04-06 | 1994-09-15 | Endocon Inc | Durch schnellschmelzen hergestellte medizinische implantate. |
DE69005800T2 (de) * | 1989-05-01 | 1994-05-19 | Alkermes Inc | Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen. |
US5019400A (en) * | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
-
1990
- 1990-06-14 FR FR9007416A patent/FR2663223B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-11 IL IL9845991A patent/IL98459A/en not_active IP Right Cessation
- 1991-06-12 CA CA002085344A patent/CA2085344C/en not_active Expired - Fee Related
- 1991-06-12 BR BR919106545A patent/BR9106545A/pt not_active Application Discontinuation
- 1991-06-12 DK DK91910762.3T patent/DK0533739T3/da active
- 1991-06-12 JP JP3510331A patent/JP2675675B2/ja not_active Expired - Lifetime
- 1991-06-12 RU RU92016471A patent/RU2104692C1/ru active
- 1991-06-12 EP EP91910762A patent/EP0533739B1/fr not_active Expired - Lifetime
- 1991-06-12 DE DE69103419T patent/DE69103419T2/de not_active Expired - Fee Related
- 1991-06-12 HU HU9203958A patent/HUT68709A/hu unknown
- 1991-06-12 KR KR1019920703205A patent/KR0157439B1/ko not_active IP Right Cessation
- 1991-06-12 AT AT91910762T patent/ATE109658T1/de not_active IP Right Cessation
- 1991-06-12 ES ES91910762T patent/ES2059142T3/es not_active Expired - Lifetime
- 1991-06-12 WO PCT/EP1991/001096 patent/WO1991019484A1/fr active IP Right Grant
- 1991-06-12 UA UA93004686A patent/UA27043C2/ru unknown
- 1991-06-12 AU AU80847/91A patent/AU661275B2/en not_active Ceased
- 1991-06-13 CZ CS19911816A patent/CZ286793B6/cs not_active IP Right Cessation
- 1991-06-13 SK SK1816-91A patent/SK280564B6/sk unknown
- 1991-06-13 IE IE201791A patent/IE62679B1/en not_active IP Right Cessation
- 1991-06-13 UY UY23240A patent/UY23240A1/es not_active IP Right Cessation
- 1991-06-13 US US07/714,583 patent/US5360616A/en not_active Expired - Lifetime
- 1991-06-14 NZ NZ238542A patent/NZ238542A/xx not_active IP Right Cessation
- 1991-06-14 TN TNTNSN91048A patent/TNSN91048A1/fr unknown
- 1991-06-14 PT PT97975A patent/PT97975B/pt not_active IP Right Cessation
- 1991-06-14 ZA ZA914550A patent/ZA914550B/xx unknown
- 1991-06-14 CN CN91104859A patent/CN1057442C/zh not_active Expired - Fee Related
- 1991-06-14 PL PL91290677A patent/PL167234B1/pl not_active IP Right Cessation
-
1992
- 1992-12-11 NO NO924792A patent/NO302998B1/no not_active IP Right Cessation
- 1992-12-11 FI FI925661A patent/FI107698B/fi active
- 1992-12-14 BG BG97166A patent/BG61179B1/bg unknown
-
1994
- 1994-05-17 US US08/243,823 patent/US5512303A/en not_active Expired - Lifetime
-
1996
- 1996-04-15 US US08/632,616 patent/US5633014A/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU92016471A (ru) | Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате | |
DE10199049I1 (de) | Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung | |
HUT55220A (en) | Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient | |
ES2010226A6 (es) | Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
IT1246188B (it) | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. | |
ATA333087A (de) | Pharmazeutisches präparat für die intravenöse wirkstoffapplikation mit hydrosolen im nanometerbereich | |
ATE109145T1 (de) | Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DE69202060T2 (de) | OPTISCH AKTIVES 5H-PYRROLO[3,4-b]PYRAZINDERIVAT, SEINE HERSTELLUNG UND PHARMAZEUTISCHE ZUBEREITUNGEN DIE ES ENTHALTEN. | |
EP0983995A3 (de) | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe | |
ATE179602T1 (de) | Stabilisierte, feste pharmazeutische zubereitung, die dextromethorphan phenylpropanolamine und coffein enthält | |
FR2601259B1 (fr) | Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives. | |
IT1230703B (it) | Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono. | |
CA2011452A1 (en) | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one | |
IL81232A0 (en) | Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof | |
IT8722264A0 (it) | Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute. | |
DE69012031T2 (de) | Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung. | |
ATE29878T1 (de) | Pharmazeutisch wirksame verbindungen und deren herstellung. | |
NO871190D0 (no) | Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider. | |
NO176180C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-karbonyl-substituerte N,N-di(trimetoksybenzoyl) piperanziner | |
DE3764233D1 (de) | Cyclopentylaether, deren herstellung und pharmazeutische formulierung. | |
DE3881812T2 (de) | Physiologisch aktive Substanzen, Probestin und Prostatin und deren Herstellung. | |
DE3773128D1 (de) | Cyclopentanaether, ihre herstellung und pharmazeutische formulierung. | |
IT8919283A0 (it) | Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s. | |
IT1201431B (it) | Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene |